These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 11714658)

  • 1. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure.
    Li D; Shinagawa K; Pang L; Leung TK; Cardin S; Wang Z; Nattel S
    Circulation; 2001 Nov; 104(21):2608-14. PubMed ID: 11714658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of the atrial fibrillation substrate in experimental congestive heart failure: angiotensin-dependent and -independent pathways.
    Cardin S; Li D; Thorin-Trescases N; Leung TK; Thorin E; Nattel S
    Cardiovasc Res; 2003 Nov; 60(2):315-25. PubMed ID: 14613861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure.
    Shi Y; Li D; Tardif JC; Nattel S
    Cardiovasc Res; 2002 May; 54(2):456-61. PubMed ID: 12062350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort.
    Li D; Fareh S; Leung TK; Nattel S
    Circulation; 1999 Jul; 100(1):87-95. PubMed ID: 10393686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 polyunsaturated fatty acids prevent atrial fibrillation associated with heart failure but not atrial tachycardia remodeling.
    Sakabe M; Shiroshita-Takeshita A; Maguy A; Dumesnil C; Nigam A; Leung TK; Nattel S
    Circulation; 2007 Nov; 116(19):2101-9. PubMed ID: 17967774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in atrial versus ventricular remodeling in dogs with ventricular tachypacing-induced congestive heart failure.
    Hanna N; Cardin S; Leung TK; Nattel S
    Cardiovasc Res; 2004 Aug; 63(2):236-44. PubMed ID: 15249181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of inhibiting Na(+)/H(+)-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling.
    Shinagawa K; Mitamura H; Ogawa S; Nattel S
    Cardiovasc Res; 2002 May; 54(2):438-46. PubMed ID: 12062348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
    Shiroshita-Takeshita A; Brundel BJ; Burstein B; Leung TK; Mitamura H; Ogawa S; Nattel S
    Cardiovasc Res; 2007 Apr; 74(1):75-84. PubMed ID: 17270161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic nature of atrial fibrillation substrate during development and reversal of heart failure in dogs.
    Shinagawa K; Shi YF; Tardif JC; Leung TK; Nattel S
    Circulation; 2002 Jun; 105(22):2672-8. PubMed ID: 12045175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in connexin expression and the atrial fibrillation substrate in congestive heart failure.
    Burstein B; Comtois P; Michael G; Nishida K; Villeneuve L; Yeh YH; Nattel S
    Circ Res; 2009 Dec; 105(12):1213-22. PubMed ID: 19875729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure.
    Cha TJ; Ehrlich JR; Zhang L; Shi YF; Tardif JC; Leung TK; Nattel S
    Circulation; 2004 Jan; 109(3):412-8. PubMed ID: 14718405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrosis and the mechanisms of atrial fibrillation.
    Everett TH; Olgin JE
    Heart Rhythm; 2007 Mar; 4(3 Suppl):S24-7. PubMed ID: 17336879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pioglitazone, a peroxisome proliferator-activated receptor-gamma activator, attenuates atrial fibrosis and atrial fibrillation promotion in rabbits with congestive heart failure.
    Shimano M; Tsuji Y; Inden Y; Kitamura K; Uchikawa T; Harata S; Nattel S; Murohara T
    Heart Rhythm; 2008 Mar; 5(3):451-9. PubMed ID: 18313605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure.
    Lee KW; Everett TH; Rahmutula D; Guerra JM; Wilson E; Ding C; Olgin JE
    Circulation; 2006 Oct; 114(16):1703-12. PubMed ID: 17030685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consequences of atrial tachycardia-induced remodeling depend on the preexisting atrial substrate.
    Shinagawa K; Li D; Leung TK; Nattel S
    Circulation; 2002 Jan; 105(2):251-7. PubMed ID: 11790709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits.
    Yamamoto T; Shimano M; Inden Y; Takefuji M; Yanagisawa S; Yoshida N; Tsuji Y; Hirai M; Murohara T
    Heart Rhythm; 2015 Jun; 12(6):1362-9. PubMed ID: 25757661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial fibrillation-associated remodeling does not promote atrial thrombus formation in canine models.
    Nishida K; Chiba K; Iwasaki YK; Katsouras G; Shi YF; Blostein MD; Khairy P; Guerra PG; Dubuc M; Tardif JC; Tanguay JF; Nattel S
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1168-75. PubMed ID: 23095228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling.
    Liu E; Xu Z; Li J; Yang S; Yang W; Li G
    Int J Cardiol; 2011 Feb; 146(3):364-70. PubMed ID: 19732978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of tetramethylpyrazine on fibrosis of atrial tissue and atrial fibrillation in a canine model of congestive heart failure induced by ventricular tachypacing].
    Lin YZ; Xu CX; Deng YL; Chen L; Huang H; Du J
    Zhong Xi Yi Jie He Xue Bao; 2006 Jan; 4(1):35-8. PubMed ID: 16409967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atrial ionic remodeling induced by atrial tachycardia in the presence of congestive heart failure.
    Cha TJ; Ehrlich JR; Zhang L; Nattel S
    Circulation; 2004 Sep; 110(12):1520-6. PubMed ID: 15381657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.